ConductScience.org, home

Library / Trials

Biology-Driven Cognitive Profiling in Huntington's Disease

NCT07503743, Active not recruiting, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Trial 8

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleBiology-Driven Cognitive Profiling in Huntington's DiseaseClinicalTrials.gov
NCT numberNCT07503743ClinicalTrials.gov
StatusActive not recruitingClinicalTrials.gov
Enrollment90 participants, actualClinicalTrials.gov
Lead sponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauClinicalTrials.gov
ConditionsHuntington's Disease (HD)ClinicalTrials.gov
First posted2026-03-31ClinicalTrials.gov
Last updated2026-03-31ClinicalTrials.gov

Registered outcomes 8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryRegional Tau PET Binding (SUVR) Using 18F-PI-2620Day 1
Standardized uptake value ratios (SUVR) derived from 18F-PI-2620 PET imaging will be calculated to quantify regional tau tracer uptake in predefined cortical and subcortical brain regions. SUVR values will be computed using the cerebellum as the reference region.
ClinicalTrials.gov
SecondaryCortical Thickness Measured by Structural MRIDay 1Mean cortical thickness (millimeters) derived from 3T structural MRI and processed using automated segmentation software (FreeSurfer).ClinicalTrials.gov
SecondarySubcortical Volume Measured by Structural MRIDay 1Regional subcortical brain volumes (mm³) derived from 3T structural MRI and processed using automated segmentation software (FreeSurfer).ClinicalTrials.gov
SecondaryPlasma Neurofilament Light Chain (NfL)Within 15 days of PET imagingConcentration of neurofilament light chain measured in plasma samples using immunoassay methods in pg/ml.ClinicalTrials.gov
SecondaryPlasma Total TauWithin 15 days of PET imagingConcentration of phosphorylated tau protein measured in plasma samples using immunoassay methods in pg/mlClinicalTrials.gov
SecondaryPlasma Phosphorylated TauWithin 15 days of PET imagingConcentration of phosphorylated tau protein measured in plasma samples using immunoassay methods in pg/mlClinicalTrials.gov
SecondaryComposite Score of Experimental Cognitive Tasks Targeting Early Huntington's Disease Cognitive ChangesWithin 15 days of PET imaging
Composite cognitive performance score derived from a set of experimental tasks designed to assess cognitive domains affected early in Huntington's disease, including attentional selection, sensory integration, visuospatial processing, temporal prediction, and cognitive control.
ClinicalTrials.gov
SecondaryGlobal Cognitive Performance Measured by Standard Neuropsychological TestsWithin 15 days of PET imaging
Scores obtained from standardized neuropsychological tests including: * Symbol Digit Modalities Test (SDMT) - processing speed * Stroop Color and Word Test - executive function and cognitive control * Trail Making Test Parts A and B - processing speed and cognitive flexibility * Verbal Fluency Test (phonemic and semantic) - executive function and language
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
42366274DERIVEDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 5

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Stroop Color-Word TestSecondary outcomeConductCognition
Symbol CodingSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition
Verbal FluencySecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)